| Receptor tyrosine kinases and cancer: oncogenic mechanisms and therapeutic approaches P Saraon, S Pathmanathan, J Snider, A Lyakisheva, V Wong, I Stagljar Oncogene 40 (24), 4079-4093, 2021 | 114 | 2021 |
| A drug discovery platform to identify compounds that inhibit EGFR triple mutants P Saraon, J Snider, Y Kalaidzidis, LE Wybenga-Groot, K Weiss, A Rai, ... Nature chemical biology 16 (5), 577-586, 2020 | 37 | 2020 |
| Drugging the undruggable proteins in cancer: a systems biology approach S Pathmanathan, I Grozavu, A Lyakisheva, I Stagljar Current Opinion in Chemical Biology 66, 102079, 2022 | 21 | 2022 |
| D154Q Mutation does not Alter KRAS Dimerization I Grozavu, S Stuart, A Lyakisheva, Z Yao, S Pathmanathan, M Ohh, ... Journal of molecular biology 434 (2), 167392, 2022 | 12 | 2022 |
| Mapping the phospho-dependent ALK interactome to identify novel components in ALK signaling F Aboualizadeh, Z Yao, J Guan, L Drecun, S Pathmanathan, J Snider, ... Journal of Molecular Biology 433 (23), 167283, 2021 | 11 | 2021 |
| Chemical Genetics Screen Identifies COPB2 Tool Compounds That Alters ER Stress Response and Induces RTK Dysregulation in Lung Cancer Cells P Saraon, J Snider, W Schormann, A Rai, N Radulovich, ... Journal of Molecular Biology 433 (23), 167294, 2021 | 8 | 2021 |
| B cell linker protein (BLNK) is a regulator of Met receptor signaling and trafficking in non-small cell lung cancer S Pathmanathan, Z Yao, P Coelho, R Valla, L Drecun, C Benz, J Snider, ... Iscience 25 (11), 2022 | 4 | 2022 |
| Mapping the MET Receptor Tyrosine Kinase Interactome using Mammalian Membrane Two Hybrid (MaMTH) system S Pathmanathan, Z Yao, J Snider, L Drecun, C Benz, Y Stern, M Park, ... The FASEB Journal 34 (S1), 1-1, 2020 | 1 | 2020 |
